Omrix's Unattributed VC - III Round

Omrix raised a round of funding on February 16, 2005. Investors include Catalyst Investors.

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…

Articles about Omrix's Unattributed VC - III Round: